Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Catheter Ablation | 7 | 2022 | 2758 | 1.660 |
Why?
|
Atrial Fibrillation | 9 | 2023 | 5034 | 1.580 |
Why?
|
Vitamin K | 3 | 2021 | 295 | 1.340 |
Why?
|
Coronary Artery Disease | 9 | 2023 | 6489 | 1.190 |
Why?
|
Thromboembolism | 2 | 2023 | 985 | 1.000 |
Why?
|
Primary Prevention | 3 | 2021 | 1167 | 0.870 |
Why?
|
Anticoagulants | 5 | 2023 | 4599 | 0.850 |
Why?
|
Atrial Appendage | 1 | 2023 | 283 | 0.700 |
Why?
|
Atherosclerosis | 4 | 2023 | 3444 | 0.650 |
Why?
|
Endocardium | 1 | 2019 | 263 | 0.630 |
Why?
|
Medication Therapy Management | 1 | 2019 | 127 | 0.620 |
Why?
|
Plaque, Atherosclerotic | 3 | 2023 | 1519 | 0.600 |
Why?
|
Bioprosthesis | 1 | 2021 | 596 | 0.580 |
Why?
|
Coronary Angiography | 5 | 2023 | 4578 | 0.570 |
Why?
|
Stroke | 5 | 2023 | 9981 | 0.550 |
Why?
|
Anticholesteremic Agents | 2 | 2023 | 979 | 0.530 |
Why?
|
Chagas Cardiomyopathy | 1 | 2015 | 72 | 0.520 |
Why?
|
Pericardium | 1 | 2019 | 667 | 0.500 |
Why?
|
Warfarin | 1 | 2021 | 1496 | 0.440 |
Why?
|
Platelet Aggregation Inhibitors | 3 | 2023 | 3068 | 0.440 |
Why?
|
Aspirin | 3 | 2021 | 3282 | 0.440 |
Why?
|
Hypercholesterolemia | 2 | 2019 | 1151 | 0.440 |
Why?
|
Guidelines as Topic | 1 | 2019 | 1404 | 0.430 |
Why?
|
Patient Admission | 1 | 2019 | 1380 | 0.410 |
Why?
|
Cryosurgery | 1 | 2016 | 452 | 0.400 |
Why?
|
Diabetes Mellitus, Type 2 | 5 | 2023 | 11732 | 0.390 |
Why?
|
Heart-Assist Devices | 1 | 2021 | 1196 | 0.390 |
Why?
|
Pulmonary Veins | 1 | 2016 | 761 | 0.370 |
Why?
|
Tachycardia, Ventricular | 1 | 2019 | 1273 | 0.370 |
Why?
|
Patient-Centered Care | 1 | 2020 | 1438 | 0.360 |
Why?
|
Heart Conduction System | 1 | 2015 | 1047 | 0.360 |
Why?
|
Coronary Artery Bypass | 2 | 2022 | 2289 | 0.350 |
Why?
|
Cardiovascular Diseases | 6 | 2021 | 15161 | 0.350 |
Why?
|
Randomized Controlled Trials as Topic | 7 | 2023 | 9960 | 0.330 |
Why?
|
Epicardial Mapping | 2 | 2019 | 57 | 0.330 |
Why?
|
Influenza, Human | 1 | 2019 | 1480 | 0.320 |
Why?
|
Cost-Benefit Analysis | 1 | 2019 | 5396 | 0.270 |
Why?
|
Hemorrhage | 4 | 2023 | 3461 | 0.270 |
Why?
|
Aortic Valve Stenosis | 3 | 2022 | 1965 | 0.250 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7281 | 0.250 |
Why?
|
Recurrence | 3 | 2022 | 8343 | 0.230 |
Why?
|
Calcinosis | 2 | 2022 | 1499 | 0.220 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2023 | 3256 | 0.210 |
Why?
|
Humans | 37 | 2024 | 744220 | 0.200 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2023 | 135 | 0.200 |
Why?
|
Heart Failure | 2 | 2023 | 10905 | 0.200 |
Why?
|
Fibrinolytic Agents | 2 | 2023 | 2158 | 0.200 |
Why?
|
Antibodies, Monoclonal | 1 | 2018 | 9275 | 0.190 |
Why?
|
Calcium | 4 | 2022 | 5757 | 0.190 |
Why?
|
Predictive Value of Tests | 5 | 2023 | 15070 | 0.190 |
Why?
|
Catheters | 1 | 2024 | 425 | 0.190 |
Why?
|
Risk Assessment | 6 | 2023 | 23337 | 0.180 |
Why?
|
Administration, Oral | 2 | 2018 | 3913 | 0.180 |
Why?
|
Action Potentials | 2 | 2019 | 1815 | 0.180 |
Why?
|
Rheumatic Heart Disease | 1 | 2021 | 177 | 0.180 |
Why?
|
Risk Factors | 10 | 2022 | 72280 | 0.180 |
Why?
|
Heart Valve Prosthesis | 2 | 2021 | 1488 | 0.180 |
Why?
|
Diuretics | 1 | 2023 | 592 | 0.180 |
Why?
|
Chi-Square Distribution | 2 | 2016 | 3509 | 0.170 |
Why?
|
Matched-Pair Analysis | 1 | 2019 | 288 | 0.170 |
Why?
|
Acute Coronary Syndrome | 2 | 2023 | 2337 | 0.170 |
Why?
|
Hypolipidemic Agents | 2 | 2020 | 604 | 0.160 |
Why?
|
Myocardial Infarction | 1 | 2019 | 11728 | 0.160 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2021 | 361 | 0.160 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2022 | 290 | 0.160 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2022 | 789 | 0.150 |
Why?
|
Aortic Valve | 3 | 2022 | 1921 | 0.150 |
Why?
|
Multiple Organ Failure | 1 | 2019 | 390 | 0.150 |
Why?
|
Brugada Syndrome | 1 | 2018 | 97 | 0.140 |
Why?
|
Phrenic Nerve | 1 | 2016 | 79 | 0.140 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2022 | 555 | 0.140 |
Why?
|
Chest Pain | 1 | 2023 | 1114 | 0.140 |
Why?
|
Heart Rate | 2 | 2019 | 4092 | 0.140 |
Why?
|
Heart Atria | 1 | 2022 | 1356 | 0.140 |
Why?
|
Brazil | 1 | 2020 | 1270 | 0.140 |
Why?
|
Asymptomatic Diseases | 1 | 2019 | 552 | 0.140 |
Why?
|
Heart Valve Diseases | 1 | 2024 | 1072 | 0.140 |
Why?
|
Coronary Vessels | 3 | 2023 | 3107 | 0.130 |
Why?
|
Treatment Outcome | 6 | 2023 | 63119 | 0.130 |
Why?
|
Cardiac Tamponade | 1 | 2016 | 173 | 0.130 |
Why?
|
Paralysis | 1 | 2016 | 249 | 0.130 |
Why?
|
Pericardial Effusion | 1 | 2016 | 247 | 0.120 |
Why?
|
Hypoglycemic Agents | 3 | 2023 | 2875 | 0.120 |
Why?
|
Atrial Flutter | 1 | 2016 | 263 | 0.120 |
Why?
|
Tachycardia, Supraventricular | 1 | 2016 | 263 | 0.120 |
Why?
|
Cardiovascular Agents | 1 | 2020 | 850 | 0.120 |
Why?
|
Prognosis | 3 | 2020 | 29050 | 0.120 |
Why?
|
Cholesterol, LDL | 2 | 2023 | 2355 | 0.120 |
Why?
|
Odds Ratio | 2 | 2016 | 9849 | 0.110 |
Why?
|
Propensity Score | 1 | 2019 | 1781 | 0.110 |
Why?
|
Death, Sudden, Cardiac | 1 | 2021 | 1541 | 0.110 |
Why?
|
Acute Kidney Injury | 2 | 2019 | 1971 | 0.090 |
Why?
|
Time Factors | 3 | 2021 | 40063 | 0.080 |
Why?
|
Middle Aged | 6 | 2023 | 213367 | 0.080 |
Why?
|
Drug Therapy, Combination | 1 | 2018 | 6485 | 0.080 |
Why?
|
Cardiology | 1 | 2019 | 1668 | 0.080 |
Why?
|
Kidney | 1 | 2023 | 7183 | 0.070 |
Why?
|
C-Reactive Protein | 1 | 2018 | 3778 | 0.070 |
Why?
|
Length of Stay | 1 | 2019 | 6308 | 0.070 |
Why?
|
Hospital Mortality | 1 | 2019 | 5316 | 0.070 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6893 | 0.070 |
Why?
|
Heart Ventricles | 1 | 2018 | 3820 | 0.070 |
Why?
|
Incidence | 2 | 2021 | 20945 | 0.060 |
Why?
|
Comorbidity | 1 | 2019 | 10387 | 0.060 |
Why?
|
Female | 8 | 2023 | 380197 | 0.060 |
Why?
|
Male | 7 | 2023 | 350027 | 0.060 |
Why?
|
Longitudinal Studies | 1 | 2020 | 13990 | 0.060 |
Why?
|
Disease Progression | 1 | 2020 | 13280 | 0.060 |
Why?
|
Gastric Inhibitory Polypeptide | 1 | 2023 | 59 | 0.060 |
Why?
|
United States | 3 | 2021 | 69867 | 0.060 |
Why?
|
Prevalence | 2 | 2021 | 15226 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 2 | 2023 | 20123 | 0.060 |
Why?
|
Age Factors | 1 | 2019 | 18367 | 0.050 |
Why?
|
Electrocardiography | 1 | 2015 | 6442 | 0.050 |
Why?
|
Aged | 4 | 2021 | 163253 | 0.050 |
Why?
|
Lipoprotein(a) | 1 | 2023 | 435 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2023 | 1107 | 0.040 |
Why?
|
Arteries | 1 | 2023 | 1119 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2021 | 57768 | 0.040 |
Why?
|
Perfusion | 1 | 2022 | 1359 | 0.040 |
Why?
|
Adult | 2 | 2020 | 214035 | 0.030 |
Why?
|
Retrospective Studies | 1 | 2023 | 77426 | 0.030 |
Why?
|
Drug-Eluting Stents | 1 | 2021 | 753 | 0.030 |
Why?
|
Renal Replacement Therapy | 1 | 2015 | 258 | 0.030 |
Why?
|
Coronary Stenosis | 1 | 2019 | 834 | 0.030 |
Why?
|
Weight Loss | 1 | 2023 | 2622 | 0.030 |
Why?
|
Echocardiography | 1 | 2024 | 5103 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2023 | 39045 | 0.020 |
Why?
|
Cause of Death | 1 | 2021 | 3584 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2213 | 0.020 |
Why?
|
Mortality | 1 | 2021 | 2864 | 0.020 |
Why?
|
Pacemaker, Artificial | 1 | 2015 | 818 | 0.020 |
Why?
|
Stents | 1 | 2019 | 3280 | 0.020 |
Why?
|
Smoking Cessation | 1 | 2019 | 2071 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15538 | 0.010 |
Why?
|
Exercise | 1 | 2019 | 5615 | 0.010 |
Why?
|
Diet | 1 | 2019 | 7937 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 53280 | 0.010 |
Why?
|
Concepts
(138)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(26)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_